Recently, RIPK3-dependent necrosis has been shown to be responsible for the mortality of septic mice induced either by TNF-α injection or polymicrobial sepsis, suggesting that targeting necrotic cells could be a novel and promising therapeutic approach for improving sepsis outcome [24,25]. This evidence concerns the gene RIPK3 and Sepsis.